High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma
Authors:
- 1 May 2016
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 34 (5) , 238.e19-238.e26
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and ElaborationPLOS Medicine, 2012
- Protective and pathogenic functions of macrophage subsetsNature Reviews Immunology, 2011
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transitionBMC Cancer, 2011
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival PatternsGenes & Cancer, 2010
- CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasisCytokine & Growth Factor Reviews, 2010
- CCL2 and Interleukin-6 Promote Survival of Human CD11b+ Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage PolarizationJournal of Biological Chemistry, 2009
- Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastasesInternational Journal of Oncology, 2009
- Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinomaCancer, 2003